INVITRO INDUCTION OF TUMOR NECROSIS FACTOR-ALPHA, TUMOR CYTOLYSIS, AND BLAST-TRANSFORMATION BY SPIROPLASMA MEMBRANES

被引:18
作者
SHER, T
YAMIN, A
ROTTEM, S
GALLILY, R
机构
[1] HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT MEMBRANES & ULTRASTRUCT RES,IL-91010 JERUSALEM,ISRAEL
[2] HEBREW UNIV JERUSALEM,HADASSAH MED SCH,LAUTENBERG CTR GEN & TUMOR IMMUNOL,IL-91010 JERUSALEM,ISRAEL
关键词
D O I
10.1093/jnci/82.13.1142
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Membranes of Spiroplasma sp. strain MQ-1 (hereafter referred to as MQ-1) were potent inducers of tumor necrosis factor α (TNFα) secretion and of blast transformation. Specific anti-recombi-nant murine TNFα antibodies markedly inhibited macrophage-mediated tumor cytolysis of A9 fibrosarcoma target cells following activation by MQ-1 membranes. Thus, TNFα plays a major role in mediation of tumor cytolysis induced by MQ-1 membranes, which is similar to its role in lipopolysaccharide (LPS)-induced tumor cytolysis. Two findings, however, suggested that the mechanism of macrophage activation by MQ-1 membranes differs from that by LPS: (a) macrophages, taken from C3H/HeJ mice showing a low responsiveness to LPS, were activated by MQ-1 membranes to enhanced TNFα secretion, resulting in a high-level tumor cytolysis compared with the negligible tumor cytolysis induced by LPS; and (b) MQ-1 membranes and LPS synergjzed to highly augment TNFα secretion by macrophages of C57BL/6 mice. MQ-1 membranes were capable of inducing blast transformation of murine lymphocytes as well. In addition, they activated human monocytes to secrete high levels of TNFα. Further studies need to be carried out using in vivo models to evaluate the therapeutic potential of MQ-1 membranes in the treatment of malignant diseases. © 1990 Oxford University Press.
引用
收藏
页码:1142 / 1145
页数:4
相关论文
共 29 条
[1]  
Barile M-F, 1985, MYCOPLASMAS, VIV, P204
[2]   TUMOR-NECROSIS-FACTOR MEDIATES ENDOTOXIC EFFECTS IN MICE [J].
BAUSS, F ;
DROGE, W ;
MANNEL, DN .
INFECTION AND IMMUNITY, 1987, 55 (07) :1622-1625
[3]   CONTROL OF CACHECTIN (TUMOR-NECROSIS-FACTOR) SYNTHESIS - MECHANISMS OF ENDOTOXIN RESISTANCE [J].
BEUTLER, B ;
KROCHIN, N ;
MILSARK, IW ;
LUEDKE, C ;
CERAMI, A .
SCIENCE, 1986, 232 (4753) :977-980
[4]  
BLOKSMA N, 1988, TUMOR NECROSIS FACTO, P171
[5]  
CHUN M, 1987, CANCER RES, V47, P115
[6]  
COLE BC, 1982, J IMMUNOL, V128, P2013
[7]   MYCOPLASMA-DEPENDENT ACTIVATION OF NORMAL LYMPHOCYTES - MITOGENIC POTENTIAL OF MYCOPLASMAS FOR MOUSE LYMPHOCYTES [J].
COLE, BC ;
ALDRIDGE, KE ;
WARD, JR .
INFECTION AND IMMUNITY, 1977, 18 (02) :393-399
[8]  
DECKER T, 1987, J IMMUNOL, V138, P957
[9]   DIRECT ACTIVATION OF THE J774.1 MURINE MACROPHAGE CELL-LINE BY MYCOPLASMA-ARTHRITIDIS [J].
DIETZ, JN ;
COLE, BC .
INFECTION AND IMMUNITY, 1982, 37 (02) :811-819
[10]   COMPARISON OF INVITRO-CELL CYTO-TOXIC ASSAYS FOR TUMOR NECROSIS FACTOR [J].
FLICK, DA ;
GIFFORD, GE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 68 (1-2) :167-175